Group One Trading
VRTX icon

Group One Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

Group One Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4M Buy
50,100
+6,700
+15% +$3.12M 0.04% 436
2025
Q4 		$19.7M Buy
43,400
+5,800
+15% +$2.5M 0.03% 561
2025
Q3 		$14.7M Buy
37,600
+900
+2% +$376K 0.03% 668
2025
Q2 		$16.3M Buy
36,700
+15,300
+71% +$7.05M 0.04% 533
2025
Q1 		$10.4M Sell
21,400
-19,700
-48% -$9.18M 0.03% 613
2024
Q4 		$16.6M Buy
41,100
+21,600
+111% +$10M 0.04% 457
2024
Q3 		$9.07M Sell
19,500
-24,300
-55% -$11.7M 0.03% 663
2024
Q2 		$20.5M Buy
43,800
+2,400
+6% +$1.04M 0.08% 194
2024
Q1 		$17.3M Sell
41,400
-13,200
-24% -$5.58M 0.07% 229
2023
Q4 		$22.2M Buy
54,600
+24,500
+81% +$9.05M 0.06% 305
2023
Q3 		$10.5M Buy
30,100
+9,200
+44% +$3.22M 0.04% 509
2023
Q2 		$7.35M Buy
20,900
+6,600
+46% +$2.22M 0.02% 702
2023
Q1 		$4.51M Sell
14,300
-30,400
-68% -$9.12M 0.02% 901
2022
Q4 		$12.9M Sell
44,700
-102,600
-70% -$31.3M 0.03% 596
2022
Q3 		$42.6M Sell
147,300
-76,900
-34% -$22.1M 0.08% 155
2022
Q2 		$63.2M Buy
224,200
+114,500
+104% +$30.6M 0.1% 140
2022
Q1 		$28.6M Sell
109,700
-54,200
-33% -$12.9M 0.03% 450
2021
Q4 		$36M Buy
163,900
+42,400
+35% +$8.24M 0.03% 412
2021
Q3 		$22M Sell
121,500
-44,800
-27% -$8.75M 0.02% 576
2021
Q2 		$33.5M Sell
166,300
-19,000
-10% -$3.97M 0.04% 379
2021
Q1 		$39.8M Sell
185,300
-8,000
-4% -$1.76M 0.06% 291
2020
Q4 		$45.7M Buy
193,300
+148,700
+333% +$34.1M 0.08% 207
2020
Q3 		$12.1M Buy
44,600
+34,400
+337% +$9.49M 0.04% 436
2020
Q2 		$2.96M Sell
10,200
-19,700
-66% -$5.34M 0.01% 1186
2020
Q1 		$7.12M Sell
29,900
-25,500
-46% -$5.85M 0.06% 377
2019
Q4 		$12.1M Buy
55,400
+28,400
+105% +$5.75M 0.08% 283
2019
Q3 		$4.57M Sell
27,000
-7,300
-21% -$1.29M 0.04% 630
2019
Q2 		$6.29M Sell
34,300
-3,400
-9% -$594K 0.06% 405
2019
Q1 		$6.93M Sell
37,700
-30,800
-45% -$5.69M 0.08% 298
2018
Q4 		$11.4M Buy
68,500
+32,800
+92% +$5.68M 0.1% 214
2018
Q3 		$6.88M Sell
35,700
-2,800
-7% -$499K 0.05% 422
2018
Q2 		$6.54M Sell
38,500
-4,700
-11% -$729K 0.06% 412
2018
Q1 		$7.04M Sell
43,200
-28,400
-40% -$4.64M 0.07% 334
2017
Q4 		$10.7M Sell
71,600
-28,300
-28% -$4.19M 0.08% 319
2017
Q3 		$15.2M Buy
99,900
+31,200
+45% +$4.7M 0.14% 153
2017
Q2 		$8.85M Sell
68,700
-10,100
-13% -$1.22M 0.09% 234
2017
Q1 		$8.62M Buy
78,800
+29,500
+60% +$2.6M 0.1% 231
2016
Q4 		$3.63M Buy
49,300
+32,000
+185% +$2.6M 0.04% 568
2016
Q3 		$1.51M Sell
17,300
-7,600
-31% -$718K 0.02% 1003
2016
Q2 		$2.14M Buy
24,900
+11,300
+83% +$976K 0.03% 788
2016
Q1 		$1.08M Buy
13,600
+3,200
+31% +$289K 0.02% 1120
2015
Q4 		$1.31M Sell
10,400
-7,000
-40% -$845K 0.02% 1128
2015
Q3 		$1.81M Sell
17,400
-5,100
-23% -$655K 0.03% 848
2015
Q2 		$2.78M Buy
22,500
+2,500
+13% +$315K 0.04% 564
2015
Q1 		$2.36M Sell
20,000
-391,900
-95% -$47M 0.04% 559
2014
Q4 		$48.9M Sell
411,900
-21,000
-5% -$2.37M 0.74% 12
2014
Q3 		$48.6M Buy
432,900
+257,000
+146% +$24.5M 0.75% 10
2014
Q2 		$16.7M Buy
175,900
+32,800
+23% +$2.3M 0.26% 55
2014
Q1 		$10.1M Sell
143,100
-49,200
-26% -$3.9M 0.17% 99
2013
Q4 		$14.3M Buy
192,300
+89,500
+87% +$6.23M 0.22% 62
2013
Q3 		$7.79M Sell
102,800
-64,300
-38% -$5.12M 0.15% 109
2013
Q2 		$13.3M Buy
+167,100
New +$12.3M 0.33% 43

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Group One Trading's VRTX Position: Q1 2026 in Review

Group One Trading opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 9,357 shares worth $4.18M. The stake represents 0.01% of the portfolio and ranks #1444 among its holdings. This is a return to the name: Group One Trading previously reported a position in VRTX as recently as Q3 2025.

Group One Trading first reported a position in VRTX in Q2 2013 and has held it in 32 quarters since. The position peaked at $23.5M in Q4 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Group One Trading held 9,357 shares of Vertex Pharmaceuticals worth $4.18M as of Q1 2026.
  • Vertex Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1444 holding.
  • Group One Trading first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Group One Trading's Vertex Pharmaceuticals position peaked at $23.5M in Q4 2020.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.